Neutralization of SARS-CoV-2 KP.1, KP.1.1, KP.2 and KP.3 by human and murine sera

期刊论文
出版模式：

开放获取
发表日期：

2024年11月11日

查看全文

Kun Xu,
Yaling An,
Xueyuan Liu,
Haitang Xie,
Dedong Li,
Ting Yang,
Minrun Duan,
Yuanzhuo Wang,
Xin Zhao,
Lianpai Dai,
George F. Gao

摘要

We report SARS-CoV-2 KP.1, KP.1.1, KP.2 and KP.3 neutralizing antibody titers. They displayed increased immune evasion compared to JN.1, especially KP.1 and KP.3, for participants who experienced BF.7/BA.5.2 breakthrough infection or received bivalent (delta/BA.5) vaccine boosting. Second XBB sub-variants breakthrough infection enhanced the neutralization responses. HK.3-JN.1 RBD-heterodimer induced balanced and potent neutralizing responses against recently-circulating SARS-CoV-2 sub-variants in mice, supporting to replace the COVID-19 antigen containing JN.1 or its sub-variants.